|
Secondary prevention
Citations 1-10 of 26 total displayed.
|
Most recent content
(1 Mar 2009):
|
- Clinical and Population Studies
Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes: Results From PROVE IT–TIMI 22
- Kausik K. Ray, Christopher P. Cannon, Richard Cairns, David A. Morrow, Paul M Ridker, and Eugene Braunwald
Arterioscler Thromb Vasc Biol 2009;29:424-430; published online before print as doi:10.1161/ATVBAHA.108.181735
[Abstract]
[Full text]
|
Past content
(since Aug 1999):
|
- Clinical and Population Studies
Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area
- Jonathan H. Klein, Robert A. Hegele, Daniel G. Hackam, Marlys L. Koschinsky, Murray W. Huff, and J. David Spence
Arterioscler Thromb Vasc Biol 2008;28:1851-1856; published online before print as doi:10.1161/ATVBAHA.108.169292
[Abstract]
[Full text]
- Atherosclerosis and Lipoproteins
Effects of Peroxisome Proliferator-Activated Receptor Ligands, Bezafibrate and Fenofibrate, on Adiponectin Level
- Aki Hiuge, Alexander Tenenbaum, Norikazu Maeda, Michal Benderly, Masahiro Kumada, Enrique Z. Fisman, David Tanne, Zipora Matas, Toshiyuki Hibuse, Koichi Fujita, Hitoshi Nishizawa, Yehuda Adler, Michael Motro, Shinji Kihara, Iichiro Shimomura, Solomon Behar, and Tohru Funahashi
Arterioscler Thromb Vasc Biol 2007;27:635-641; published online before print as doi:10.1161/01.ATV.0000256469.06782.d5
[Abstract]
[Full text]
- Editorials
Lipoprotein Retention—and Clues for Atheroma Regression
- Kevin Jon Williams and Ira Tabas
Arterioscler Thromb Vasc Biol 2005;25:1536-1540, doi:10.1161/01.ATV.0000174795.62387.d3
[Abstract]
[Full text]
- Atherosclerosis and Lipoproteins
Fenofibric Acid, an Active Form of Fenofibrate, Increases Apolipoprotein A-I–Mediated High-Density Lipoprotein Biogenesis by Enhancing Transcription of ATP-Binding Cassette Transporter A1 Gene in a Liver X Receptor–Dependent Manner
- Reijiro Arakawa, Norimasa Tamehiro, Tomoko Nishimaki-Mogami, Kazumitsu Ueda, and Shinji Yokoyama
Arterioscler Thromb Vasc Biol 2005;25:1193-1197; published online before print as doi:10.1161/01.ATV.0000163844.07815.c4
[Abstract]
[Full text]
- Special Article
Aspirin and Clopidogrel: Efficacy, Safety, and the Issue of Drug Resistance
- Marco Cattaneo
Arterioscler Thromb Vasc Biol 2004;24:1980-1987; published online before print as doi:10.1161/01.ATV.0000145980.39477.a9
[Abstract]
[Full text]
- Atherosclerosis and Lipoproteins
Cholesterol-Lowering Independent Regression and Stabilization of Atherosclerotic Lesions by Pravastatin and by Antimonocyte Chemoattractant Protein-1 Therapy in Nonhuman Primates
- Shiro Kitamoto, Kaku Nakano, Yasuhiko Hirouchi, Yoshiro Kohjimoto, Shunichi Kitajima, Makoto Usui, Shujiro Inoue, and Kensuke Egashira
Arterioscler Thromb Vasc Biol 2004;24:1522-1528; published online before print as doi:10.1161/01.ATV.0000134518.27241.da
[Abstract]
[Full text]
- Atherosclerosis and Lipoproteins
Clinical and Biochemical Results of the Metalloproteinase Inhibition with Subantimicrobial Doses of Doxycycline to Prevent Acute Coronary Syndromes (MIDAS) Pilot Trial
- David L. Brown, Kavita K. Desai, Babak A. Vakili, Chadi Nouneh, Hsi-Ming Lee, and Lorne M. Golub
Arterioscler Thromb Vasc Biol 2004;24:733-738; published online before print as doi:10.1161/01.ATV.0000121571.78696.dc
[Abstract]
[Full text]
- AHA Scientific Statements
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
- Lori Mosca, Lawrence J. Appel, Emelia J. Benjamin, Kathy Berra, Nisha Chandra-Strobos, Rosalind P. Fabunmi, Deborah Grady, Constance K. Haan, Sharonne N. Hayes, Debra R. Judelson, Nora L. Keenan, Patrick McBride, Suzanne Oparil, Pamela Ouyang, Mehmet C. Oz, Michael E. Mendelsohn, Richard C. Pasternak, Vivian W. Pinn, Rose Marie Robertson, Karin Schenck-Gustafsson, Cathy A. Sila, Sidney C. Smith, Jr, George Sopko, Anne L. Taylor, Brian W. Walsh, Nanette K. Wenger, Christine L. Williams Expert Panel/Writing Group
Arterioscler Thromb Vasc Biol 2004;24:e29-50e, doi:10.1161/01.ATV.0000114834.85476.81
[Full text]
- AHA Scientific Statements
Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease: A Statement From the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity)
- Paul D. Thompson, David Buchner, Ileana L. Piña, Gary J. Balady, Mark A. Williams, Bess H. Marcus, Kathy Berra, Steven N. Blair, Fernando Costa, Barry Franklin, Gerald F. Fletcher, Neil F. Gordon, Russell R. Pate, Beatriz L. Rodriguez, Antronette K. Yancey, and Nanette K. Wenger
Arterioscler Thromb Vasc Biol 2003;23:e42-49e, doi:10.1161/01.ATV.0000089628.63625.D4
[Full text]
|
|
